analysis of chronic obstructive pulmonary disease complicated by pulmonary fibrosis clinical（分析慢性阻塞性肺疾病肺纤维化的临床复杂）.docVIP

Analysis of chronic obstructive pulmonary disease complicated by pulmonary fibrosis clinical [Words] of chronic obstructive pulmonary disease (COPD, pulmonary fibrosis (PF, clinical features 1 Clinical data 200 001/200 601 hospitalized in our department with chronic obstructive pulmonary disease (COPD) with pulmonary interstitial fibrosis (PF COPD group, 10 (8 males and 2 females, aged 60 to 82 (mean 70.4 years, COPD diagnosis Chinese Medical Association established diagnostic criteria [1], and in the course of imaging pulmonary fibrosis. diagnosis is based on: ① the clinical features of COPD and concomitant PF characteristics, such as Velcro rales, clubbing (toe lung volume without reducing ② X-ray, CT or high-resolution CT (HRCT with COPD and PF change the ③ lung function: mixed or obstructive ventilatory dysfunction [2]. simply COPD patients 12 (10 male and 2 females, aged 64 to 81 (average 71.8 years of age, gender, age and PF COPD group had no significant difference. comparative analysis of two groups of patients with clinical symptoms and signs, X-ray, CT and high-resolution CT (HRCT, lung function and blood gas analysis results. comparison of COPD and the PF  COPD clinical characteristics (including signs, X-ray, CT or HRCT, blood gas analysis, between the two groups in a barrel chest, lung bounded down temperature rales, Velcro rales, clubbing other signs of difference had statistical significance (P lt;0.05, X-line chest radiographs and CT or HRCT statistical difference was found. pulmonary function tests PF COPD group were not simply restricted breathing disorders mixed ventilatory defect in 7 cases (70%), obstructive ventilatory dysfunction 2 cases (20%, simple COPD group were suggestive of a purely obstructive ventilatory dysfunction. 2 Discussion COPD is chronic obstructive airway lumen to expand and pulmonary elasticity decreased pulmonary fibrosis (PF is the alveolar wall destruction and restricted diffusion barriers and alveolar expa